Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin A | 8 | 2022 | 111 | 3.710 |
Why?
|
| Zebrafish Proteins | 6 | 2020 | 100 | 1.810 |
Why?
|
| Vision, Ocular | 3 | 2022 | 68 | 1.730 |
Why?
|
| Retina | 5 | 2022 | 252 | 1.660 |
Why?
|
| Retinoids | 3 | 2022 | 122 | 1.520 |
Why?
|
| Eye | 3 | 2021 | 89 | 1.490 |
Why?
|
| Retinal Degeneration | 3 | 2022 | 75 | 1.450 |
Why?
|
| Membrane Transport Proteins | 2 | 2021 | 81 | 1.360 |
Why?
|
| Eye Proteins | 3 | 2021 | 160 | 1.340 |
Why?
|
| Photoreceptor Cells | 4 | 2021 | 62 | 1.260 |
Why?
|
| Photoreceptor Cells, Vertebrate | 2 | 2018 | 46 | 1.180 |
Why?
|
| beta-Carotene 15,15'-Monooxygenase | 3 | 2011 | 3 | 1.120 |
Why?
|
| Zebrafish | 11 | 2022 | 187 | 1.060 |
Why?
|
| Diet | 3 | 2021 | 514 | 1.030 |
Why?
|
| Oxygenases | 3 | 2012 | 8 | 0.910 |
Why?
|
| Carotenoids | 3 | 2012 | 45 | 0.900 |
Why?
|
| Cilia | 3 | 2019 | 94 | 0.870 |
Why?
|
| beta Carotene | 3 | 2013 | 16 | 0.840 |
Why?
|
| Homeostasis | 3 | 2020 | 291 | 0.830 |
Why?
|
| Transcription Factors | 4 | 2021 | 753 | 0.750 |
Why?
|
| Rhodopsin | 1 | 2021 | 135 | 0.740 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 248 | 0.730 |
Why?
|
| Cell Survival | 2 | 2020 | 901 | 0.710 |
Why?
|
| Animals | 23 | 2022 | 20880 | 0.710 |
Why?
|
| Endoplasmic Reticulum | 3 | 2016 | 148 | 0.660 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2009 | 108 | 0.650 |
Why?
|
| Retinal Photoreceptor Cell Outer Segment | 1 | 2017 | 1 | 0.620 |
Why?
|
| Mice | 15 | 2022 | 8474 | 0.620 |
Why?
|
| Adenosine Triphosphate | 2 | 2009 | 314 | 0.590 |
Why?
|
| Exocytosis | 1 | 2017 | 34 | 0.590 |
Why?
|
| Morphogenesis | 1 | 2017 | 158 | 0.590 |
Why?
|
| Vesicular Transport Proteins | 4 | 2021 | 87 | 0.520 |
Why?
|
| Protein Transport | 5 | 2022 | 280 | 0.510 |
Why?
|
| Mutation | 4 | 2017 | 1213 | 0.470 |
Why?
|
| Intestinal Mucosa | 2 | 2018 | 219 | 0.470 |
Why?
|
| Mice, Knockout | 9 | 2022 | 1692 | 0.430 |
Why?
|
| PPAR gamma | 2 | 2010 | 95 | 0.430 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2009 | 6 | 0.420 |
Why?
|
| Exfoliation Syndrome | 2 | 2022 | 2 | 0.410 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 157 | 0.410 |
Why?
|
| Scavenger Receptors, Class B | 2 | 2015 | 18 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 8 | 2021 | 2791 | 0.390 |
Why?
|
| Intestinal Absorption | 4 | 2018 | 41 | 0.370 |
Why?
|
| Mitochondria | 2 | 2012 | 643 | 0.360 |
Why?
|
| Adipocytes | 1 | 2010 | 88 | 0.350 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 186 | 0.340 |
Why?
|
| Vision Disorders | 2 | 2021 | 94 | 0.330 |
Why?
|
| Carrier Proteins | 2 | 2022 | 597 | 0.310 |
Why?
|
| Liver | 4 | 2020 | 1118 | 0.310 |
Why?
|
| Membrane Proteins | 3 | 2021 | 617 | 0.300 |
Why?
|
| Thyroid Neoplasms | 1 | 2008 | 68 | 0.300 |
Why?
|
| Apoptosis | 2 | 2016 | 1641 | 0.280 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2010 | 48 | 0.270 |
Why?
|
| Unfolded Protein Response | 2 | 2016 | 70 | 0.260 |
Why?
|
| Colorectal Neoplasms | 2 | 2008 | 560 | 0.260 |
Why?
|
| Mutation, Missense | 2 | 2016 | 112 | 0.250 |
Why?
|
| Humans | 21 | 2022 | 68549 | 0.250 |
Why?
|
| Protein Binding | 4 | 2021 | 1027 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2017 | 328 | 0.220 |
Why?
|
| Electroretinography | 2 | 2021 | 122 | 0.220 |
Why?
|
| Blotting, Western | 3 | 2016 | 954 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2012 | 718 | 0.220 |
Why?
|
| Retinol-Binding Proteins | 1 | 2022 | 28 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1663 | 0.210 |
Why?
|
| Mammals | 1 | 2022 | 47 | 0.210 |
Why?
|
| Fatty Acid Desaturases | 2 | 2012 | 3 | 0.200 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2022 | 71 | 0.200 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2021 | 1 | 0.200 |
Why?
|
| LIM-Homeodomain Proteins | 1 | 2021 | 4 | 0.200 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2021 | 3 | 0.200 |
Why?
|
| Glaucoma | 1 | 2022 | 50 | 0.200 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2021 | 19 | 0.200 |
Why?
|
| Retinal Cone Photoreceptor Cells | 1 | 2022 | 74 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 3 | 2015 | 614 | 0.200 |
Why?
|
| Dyneins | 1 | 2021 | 10 | 0.200 |
Why?
|
| Biological Transport | 1 | 2021 | 210 | 0.190 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2021 | 63 | 0.190 |
Why?
|
| Tretinoin | 2 | 2013 | 92 | 0.190 |
Why?
|
| Retinol-Binding Proteins, Plasma | 2 | 2018 | 12 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2012 | 282 | 0.180 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 337 | 0.180 |
Why?
|
| Phenotype | 2 | 2021 | 946 | 0.170 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2021 | 145 | 0.170 |
Why?
|
| Germ-Line Mutation | 2 | 2009 | 43 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2022 | 627 | 0.160 |
Why?
|
| Kidney Tubules | 1 | 2019 | 80 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 1533 | 0.160 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 123 | 0.160 |
Why?
|
| Cysts | 1 | 2019 | 70 | 0.160 |
Why?
|
| Cell Line | 4 | 2021 | 1752 | 0.160 |
Why?
|
| Enterocytes | 1 | 2017 | 7 | 0.150 |
Why?
|
| Larva | 1 | 2018 | 39 | 0.150 |
Why?
|
| 3T3 Cells | 1 | 2018 | 124 | 0.150 |
Why?
|
| Kidney | 2 | 2021 | 945 | 0.150 |
Why?
|
| Aortic Valve | 1 | 2019 | 249 | 0.150 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 177 | 0.150 |
Why?
|
| DNA, Complementary | 2 | 2019 | 251 | 0.150 |
Why?
|
| MicroRNAs | 1 | 2022 | 447 | 0.140 |
Why?
|
| Pancreas | 1 | 2018 | 225 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 196 | 0.140 |
Why?
|
| Electroporation | 1 | 2016 | 11 | 0.140 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2013 | 30 | 0.130 |
Why?
|
| Hepatocytes | 1 | 2017 | 205 | 0.130 |
Why?
|
| Transfection | 1 | 2018 | 782 | 0.130 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2016 | 160 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2021 | 2689 | 0.130 |
Why?
|
| Base Sequence | 3 | 2015 | 1015 | 0.130 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 742 | 0.130 |
Why?
|
| Dioxygenases | 2 | 2012 | 2 | 0.130 |
Why?
|
| Zeaxanthins | 1 | 2015 | 2 | 0.130 |
Why?
|
| Xanthophylls | 1 | 2015 | 4 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 1293 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 2016 | 236 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2016 | 271 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2016 | 215 | 0.120 |
Why?
|
| Heart Defects, Congenital | 1 | 2019 | 596 | 0.120 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1851 | 0.120 |
Why?
|
| 3T3-L1 Cells | 2 | 2010 | 30 | 0.110 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 37 | 0.110 |
Why?
|
| Animal Feed | 1 | 2013 | 52 | 0.110 |
Why?
|
| Case-Control Studies | 3 | 2022 | 1549 | 0.110 |
Why?
|
| Female | 9 | 2021 | 38021 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 114 | 0.110 |
Why?
|
| Heterozygote | 1 | 2013 | 174 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2012 | 24 | 0.110 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 357 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2013 | 161 | 0.100 |
Why?
|
| Fenretinide | 1 | 2012 | 26 | 0.100 |
Why?
|
| Male | 8 | 2021 | 37283 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 381 | 0.100 |
Why?
|
| Anemia | 1 | 2012 | 104 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 298 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 307 | 0.090 |
Why?
|
| Models, Biological | 2 | 2012 | 981 | 0.090 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2010 | 6 | 0.090 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 434 | 0.090 |
Why?
|
| DNA | 1 | 2013 | 597 | 0.090 |
Why?
|
| Mitochondria, Liver | 1 | 2011 | 148 | 0.090 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2009 | 12 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 52 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 196 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 282 | 0.090 |
Why?
|
| Intestines | 1 | 2010 | 114 | 0.080 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 77 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2012 | 296 | 0.080 |
Why?
|
| Adiposity | 1 | 2009 | 88 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2009 | 165 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2010 | 1034 | 0.080 |
Why?
|
| Colon | 1 | 2010 | 168 | 0.080 |
Why?
|
| Succinate Dehydrogenase | 1 | 2008 | 13 | 0.080 |
Why?
|
| Adipose Tissue | 1 | 2009 | 221 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 710 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2022 | 786 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2008 | 220 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2008 | 305 | 0.070 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1082 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1446 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2021 | 1200 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2673 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2004 | 22 | 0.060 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 40 | 0.060 |
Why?
|
| Genomic Instability | 1 | 2004 | 41 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 194 | 0.050 |
Why?
|
| Saudi Arabia | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ribonuclease III | 1 | 2022 | 16 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2022 | 20 | 0.050 |
Why?
|
| Intercellular Junctions | 1 | 2021 | 32 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 226 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 2021 | 143 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2021 | 274 | 0.050 |
Why?
|
| Kidney Glomerulus | 1 | 2021 | 155 | 0.050 |
Why?
|
| Podocytes | 1 | 2021 | 113 | 0.040 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2019 | 22 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 207 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2013 | 682 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2019 | 204 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 455 | 0.040 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 240 | 0.040 |
Why?
|
| Dogs | 1 | 2019 | 490 | 0.040 |
Why?
|
| Genotype | 1 | 2019 | 785 | 0.040 |
Why?
|
| Qa-SNARE Proteins | 1 | 2016 | 5 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 2019 | 307 | 0.030 |
Why?
|
| Transcription Factor CHOP | 1 | 2016 | 28 | 0.030 |
Why?
|
| Heat-Shock Proteins | 1 | 2016 | 69 | 0.030 |
Why?
|
| Protein Folding | 1 | 2016 | 82 | 0.030 |
Why?
|
| eIF-2 Kinase | 1 | 2016 | 49 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 99 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 44 | 0.030 |
Why?
|
| Solubility | 1 | 2015 | 134 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 284 | 0.030 |
Why?
|
| Synapses | 1 | 2016 | 222 | 0.030 |
Why?
|
| PPAR delta | 1 | 2013 | 14 | 0.030 |
Why?
|
| Binding Sites | 1 | 2015 | 631 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 254 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2013 | 128 | 0.030 |
Why?
|
| Gene Expression | 1 | 2015 | 770 | 0.030 |
Why?
|
| Gene Library | 1 | 2010 | 68 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 68 | 0.020 |
Why?
|
| COS Cells | 1 | 2010 | 155 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2010 | 45 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 1174 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2010 | 234 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 630 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2009 | 6 | 0.020 |
Why?
|
| Diterpenes | 1 | 2009 | 42 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7268 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2009 | 112 | 0.020 |
Why?
|
| Weight Gain | 1 | 2009 | 135 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 499 | 0.020 |
Why?
|
| Loss of Heterozygosity | 1 | 2004 | 25 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 159 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 386 | 0.010 |
Why?
|
| Aged | 1 | 2008 | 14842 | 0.010 |
Why?
|
| Middle Aged | 1 | 2008 | 21119 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 21379 | 0.010 |
Why?
|